These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group. Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175 [TBL] [Abstract][Full Text] [Related]
4. Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina. Parker JD; Parker AB; Farrell B; Parker JO Circulation; 1996 Feb; 93(4):691-6. PubMed ID: 8640997 [TBL] [Abstract][Full Text] [Related]
5. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval. Schaer DH; Buff LA; Katz RJ Am J Cardiol; 1988 Jan; 61(1):46-50. PubMed ID: 3122549 [TBL] [Abstract][Full Text] [Related]
6. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina]. Cianfrocca C; Sabia R; Zoboli S; Bugiardini R G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869 [TBL] [Abstract][Full Text] [Related]
7. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin. Nabel EG; Barry J; Rocco MB; Mead K; Selwyn AP Am J Cardiol; 1989 Mar; 63(11):663-9. PubMed ID: 2493732 [TBL] [Abstract][Full Text] [Related]
8. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA; JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593 [TBL] [Abstract][Full Text] [Related]
9. Sustained high-dose nitroglycerin transcutaneous patch therapy in angina pectoris: evidence for attenuation of effect over time. Frishman WH; Giles T; Greenberg S; Heiman M; Raffidal L; Soberman J; Laifer L; Nadelmann J; Lazar E; Strom J J Clin Pharmacol; 1989 Dec; 29(12):1097-105. PubMed ID: 2515215 [TBL] [Abstract][Full Text] [Related]
10. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. DeMots H; Glasser SP J Am Coll Cardiol; 1989 Mar; 13(4):786-95. PubMed ID: 2494240 [TBL] [Abstract][Full Text] [Related]
11. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Thadani U; Hamilton SF; Olson E; Anderson J; Voyles W; Prasad R; Teague SM Ann Intern Med; 1986 Oct; 105(4):485-92. PubMed ID: 3092711 [TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris. de Milliano PA; Koster RW; Bär FW; Janssen J; de Cock C; Schelling A; van de Bos A Am J Cardiol; 1991 Oct; 68(9):857-62. PubMed ID: 1927943 [TBL] [Abstract][Full Text] [Related]
13. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris. Rezaković DE; Pavicić L; Majacić M Eur Heart J; 1988 Jan; 9 Suppl A():73-81. PubMed ID: 3137073 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris. Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635 [TBL] [Abstract][Full Text] [Related]
15. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group. Scardi S; Camerini F; Pandullo C; Pollavini G Int J Cardiol; 1991 Aug; 32(2):241-8. PubMed ID: 1917174 [TBL] [Abstract][Full Text] [Related]
17. Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch-free period. Whalley DW; Hellestrand KJ Aust N Z J Med; 1990 Oct; 20(5):677-81. PubMed ID: 2126727 [TBL] [Abstract][Full Text] [Related]
18. Transdermal nitroglycerin reduces the frequency of anginal attacks but fails to prevent silent ischemia. Rossetti E; Luca C; Bonetti F; Chierchia SL J Am Coll Cardiol; 1993 Feb; 21(2):337-42. PubMed ID: 8425995 [TBL] [Abstract][Full Text] [Related]
19. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application. Luke R; Sharpe N; Coxon R J Am Coll Cardiol; 1987 Sep; 10(3):642-6. PubMed ID: 3114351 [TBL] [Abstract][Full Text] [Related]
20. Discontinuous transdermal nitroglycerin as treatment for stable angina in the elderly: a double-blind multicentre study. The Transdermal TNG Trial Group of Istituto Nazionale Ricovero e Cura Anziani (I.N.R.C.A.). Paciaroni E; Luca C Eur Heart J; 1991 Oct; 12(10):1076-80. PubMed ID: 1782932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]